Literature DB >> 12587940

Inflammation and Alzheimer's disease.

A Gupta1, K Pansari.   

Abstract

Alzheimer's disease (AD) is classified mainly as a neurodegenerative disease. Recent research, however, has shown that inflammatory mechanisms are also associated with AD and that they could have a role in contributing to the pathogenesis of this disease. The evidence is based on histopathological brain studies, laboratory studies of peripheral inflammation and the fact that certain anti-inflammatory drugs could modify the course of AD. There is wide scope for further research using anti-inflammatory therapies in the prevention/treatment of AD, thereby reducing the burden of this widely prevalent condition in the community.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587940

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  12 in total

Review 1.  Assessing cell and organ senescence biomarkers.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

2.  Progress in the development of new drugs in Alzheimer's disease.

Authors:  Antoine Piau; F Nourhashémi; C Hein; C Caillaud; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-01       Impact factor: 4.075

3.  Curcumin, inflammation, ageing and age-related diseases.

Authors:  E Sikora; Giovanni Scapagnini; Mario Barbagallo
Journal:  Immun Ageing       Date:  2010-01-17       Impact factor: 6.400

Review 4.  Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.

Authors:  Mohammad A Kamal; Shubha Priyamvada; Arivarasu N Anbazhagan; Nasimudeen R Jabir; Shams Tabrez; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

5.  Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells.

Authors:  Jian-Guo Cui; Hitoshi Kuroda; N Vishvanath Chandrasekharan; Ricardo Palacios Pelaez; Daniel L Simmons; Nicolas G Bazan; Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

6.  Association of C-reactive protein with cognitive impairment.

Authors:  James M Noble; Jennifer J Manly; Nicole Schupf; Ming Xing Tang; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2010-01

7.  Lovastatin inhibits amyloid precursor protein (APP) beta-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts.

Authors:  Je-Seong Won; Yeong-Bin Im; Mushfiquddin Khan; Miguel Contreras; Avtar K Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2008-02-05       Impact factor: 5.372

8.  Signaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cells.

Authors:  Michael S Thomas; Wenru Zhang; Paivi M Jordan; H Uri Saragovi; Giulio Taglialatela
Journal:  J Neuroinflammation       Date:  2005-09-06       Impact factor: 8.322

9.  Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease.

Authors:  Anastazija Gnjec; Katarzyna J D'Costa; Simon M Laws; Ross Hedley; Kelvin Balakrishnan; Kevin Taddei; Georgia Martins; Athena Paton; Giuseppe Verdile; Samuel E Gandy; G Anthony Broe; William S Brooks; Hayley Bennett; Olivier Piguet; Patricia Price; Judith Miklossy; Joachim Hallmayer; Patrick L McGeer; Ralph N Martins
Journal:  J Neuroinflammation       Date:  2008-08-20       Impact factor: 8.322

10.  Using animal models to determine the significance of complement activation in Alzheimer's disease.

Authors:  David A Loeffler
Journal:  J Neuroinflammation       Date:  2004-10-12       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.